What can we help you find?
Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.
Paul Dobesh, PharmD, and James Groce III, PharmD, provide some final thoughts on the future of CAD/PAD management.
Review of the pharmacist’s role in outpatient care for acute myeloid leukemia.
John Beckner, RPh, Senior Director of Strategic Initiatives at NCPA, discusses the role of the community pharmacy in the age of COVID-19 in supporting current health care efforts, such as continuing immunizations and managing the effects of the pandemic on patients.
John Beckner, RPh, Senior Director of Strategic Initiatives at NCPA, discusses the value of a pharmacist today.
Description of the traditional inpatient administrations versus outpatient treatment processes in acute myeloid leukemia.
Gregory Leighton, RPh, vice president of clinical solutions and patient access for Asembia, discusses considerations for reaching the end goal of a patient’s journey with specialty pharmacy.
Autumn Zuckerman, director of specialty pharmacy at Vanderbilt University Medical Center, and JoAnn Stubbings, a professor at the University of Illinois at Chicago College of Pharmacy, discuss the role of specialty pharmacists in guiding patients throughout their journey.
Key opinion leaders discuss the need to educate patients and physicians and the potential consequences of managing CAD/PAD without proper data support or understanding.
Experts discuss the identification and Medical Utilization Evaluation of patients with newly diagnosed acute myeloid leukemia.
Experts in the field of CAD/PAD management provide personal insight into interchanging anticoagulants and minimizing confusion of the different DOACs at 2.5-mg strength.
Jonathan Ogurchak, PharmD, CSP, discusses the improtance of combining technology with the personal touch in specialty pharmacy.